While fully synthetic, Polymedics' skin substitutes exert profound biological effects through their degradation. As these products integrate and get degraded by the native tissue in the wound bed, their polylactic acid chains get cleaved down to lactide monomers, which in turn are metabolized to lactate by surrounding cells. Lactate has traditionally been regarded as a waste product of cellular metabolism; however, mounting evidence demonstrates it exerts potent effects: 1) it induces the formation of new blood vessels (neo-angiogenesis); 2) it promotes cell survival, proliferation, and deposition of extracellular matrix; 3) it regulates the inflammatory environment; and 4) acidifies the extracellular environment through the conversion f lactate into lactic acid. Taken together, these effects are translated into faster and better wound healing.
Suprathel, a synthetic, resorbable epidermal membrane, is commonly used to treat superficial and partial-thickness burns and donor sites for skin grafts. Its flexible, transparent structure conforms closely to wound surfaces, providing effective protection while allowing gas exchange and maintaining moisture balance. This creates an optimal microenvironment for healing, significantly reduces pain, and eliminates the need for frequent dressing changes, significantly improving patient comfort. Clinical studies have shown that Suprathel supports rapid re-epithelialization, reduces scarring compared to traditional dressings, and reduces the need for opioid medication in burn patients.
Supra SDRM (Synthetic Dermal Regeneration Matrix) expands on these advantages for deeper injuries, complex soft tissue defects due to infection or trauma, and chronic wounds such as venous leg ulcers and diabetic ulcers. Its high porosity is ideally suited to enhance cell adhesion, angiogenesis, and extracellular matrix deposition, leading to healing soft tissue and dermal structures. Clinical evidence demonstrates that Supra SDRM reduces by half the time needed to achieve the complete closure of chronic wounds while lowering costs and providing a higher quality of life.
After cleaning and debridement, the wounded areas were covered with Suprathel® membranes. Suprathel® initially looks white and opaque, but as it heats up to the body's temperature, it becomes translucent, allowing the visualization of the wound bed and monitoring of wound healing. It is designed to stay in place for 10 to 14 days, after which it self-degrades and may require re-application. Shortly after application, the patient reported a significant decrease in the associated pain. The material self-adheres only to wounds and conforms to the wound bed, as seen in the image. Supra Net(R) was then used as a non-adhesive, non-contact layer to protect the graft. Supra Net(R) is a highly porous silicon-nylon mesh with good adherence to intact skin and very low adherence to Suprathel and wounded areas. It is ideal for ensuring intimate contact of the synthetic skin to the wound bed and allowing fluid exchange. These layers are then covered by a secondary dressing that can be changed as often as needed until the next visit to the clinic.SUPRATHEL® is purely synthetic and therefore does not bear any residual risks as is the case with biological products of human or animal origin. Literature suggests that lactate may stimulate the healing process by supporting angiogenesis1-6 and the re-building of the dermis. The potential of lactate to act as a free radical scavenger and therefore to be able to reduce oxidative stress.
These synthetic skin substitutes represent a paradigm shift in wound care. Their ability to mimic the biological functions of human skin, combined with the bioactive properties of components like lactate, makes them a versatile and effective option for treating burns and chronic wounds. They improve healing outcomes while reducing complications and treatment costs.
As a clinical researcher and a medical validator, my unique commitment to explore new medical innovations often introduces me to some of the most ground-breaking technologies and the best and brightest clinical or engineering minds behind them. I am tasked to validate their efficacy with medical imaging and report on their ability to integrate with our current modalities.
In the spring of 2024, I traveled to Montreal Canada (McGill University) to meet Dr. Jose Ramirez-GarciaLuna, "The Wound Scientist"- who was undergoing dedicated clinical evaluation efforts to measure the severity of burn wounds. Helped me uncover the intricacies of wound healing and the many resources that comprise this highly valued study. His work led to the use of infrared thermography to identify soft tissue viability to assess burn depth. In support of this project, he also introduced the impressive properties and effects of the highly developed SYNTHETIC SKIN- what is obviously a major game-changer in burn care and traumatic injuries.
It was here that my attention was drawn to an exciting avenue of clinical care and an area where my diagnostic prowess and imaging expertise could contribute to furthering its advancement. The application of this critical care science has come a long way in the managing of burns, extreme skin disorders or post-surgical lacerations. Dr. GarciaLuna and I had great discussions about the many possibilities of integrating regenerative technologies to optimizing the healing of bodily damage, and our collaboration continues to grow at this present day.
DR. JOSE L. RAMIREZ-GARCIALUNA earned his MD and an MSc in epidemiology and biostatistics from Universidad Autonoma de San Luis Potosi, in Mexico. He practiced for five years as an emergency and critical care physician before earning a Ph.D. in experimental surgery at McGill University, Canada. In addition, he holds graduate diplomas in surgical innovation, machine learning, and data science. Dr. Ramirez-GarciaLuna's areas of expertise include wound healing research, the immunology of wound healing, surgical innovation, and e-Health. For the past 10-years, he has used spectral imaging, infrared thermography, machine learning, and artificial intelligence for a plethora of surgical problems, including wound healing and COVID-19 infection detection. He has authored over 80 peer-reviewed articles, and his research has been awarded multiple accolades, including McGill University's Rising Star Award and the distinction as a Fellow of the Mexican National Council for Science and Technology. Dr. Ramirez-Garcialuna is the Director of Medical Affairs for Polymedics Innovations, a company focused on developing synthetic skin substitutes, and is a medical and scientific consultant for several biotech companies. He is also affiliated with the Division of Experimental Surgery of McGill University, Canada and as an Adjunct Professor in the Department of Surgery of Universidad Autonoma de San Luis Potosi, Mexico.
From a recorded interview with DR. ROBERT L. BARD (of BardDiagnostics lab)
INTRODUCTION: The following is an abridged private performance study of a multi-diagnostic reporting paradigm of thermographic imaging (FLIR) and ultrasound/ 3D Doppler microvascular blood flow imaging (CANON) to report on various wound healing applications. Dr. Robert Bard, functional diagnostic imaging specialist partnered with Dr. Jose Garcialuna in the implementation of image-guided treatments of a traumatic and inflammatory skin disorders and the application of synthetic skin. This study was performed in a closed setting under strict monitoring of the patient’s time-based progress. The collaboration between the diagnostic team and Dr. Garcialuna supports the use of multi-factorial data to detect treatment efficacy and improved recovery time alongside the severity of the pathological condition of the subject/patient. Comparison of the bilateral inflammatory changes on this patient with hemolytic autoimmune anemia (which flared after trauma to the dorsum of the left foot) shows that the lower tibial area is wet and inflamed - a so-called weeping or active wound. The left foot, whose magnification [image #1] shows that the wounds are dry as compared to the weeping wound.
ABSTRACT: Inflammatory disease of
the skin, which includes burns and diseases like psoriasis demonstrates
thickened epidermis and dermis with increased intra and subdermal vascularity -
all of which are measured by the out flow imaging and verified by other
micro-imaging device technologies to confirm the epidermal and dermal extent of
the disease. The blood flow, quantified either by 4-D ultrasound or by the
optical vascular imaging may be used as a marker of treatment and noninvasive guide
to adjust therapy without biopsy.
THERMOGRAPHY represents healing wound physiology as follows: inflamed areas are higher temperature (lighter color) while healing tissue or are starting to ‘fibrose’ and scar down are identified as darker colors. These measurements serve as treatment guides of inflammation before, during, and after treatment as part of a noninvasive methodology to follow up in post-care. [Image #3] Thermographic imaging (with a high resolution FLIR or infrared camera) indicates specific areas that appear dark, indicating that the wound is starting to fibrose due to elevated blood supply.
[Image
#4 R-L] REFLECTANCE CONFOCAL MICROSCOPY shows inflammatory disease neovascularity
with cutaneous lupus. The red and black scans (#4-L) with high resolution
OCT or OPTICAL COMPUTED TOMOGRAPHY images of the inflammatory blood supply
documents, which subsides in intensity as the wound is healing.
[Image #5] 3D DOPPLER ULTRASOUND IMAGING represents the dermal edema (arrow) and the subcutaneous tissues with hypervascularity. This includes a major vessel that is hypertrophied - supplying the inflamed tissues in the center right with a bright yellow image of the blood flow surrounded by a darker area of inflammatory edematous inflammatory disease is focused at the deeper level, which is impossible to see with the human eye and certainly best image with 3D, ultrasound and doppler.
Part 3:
BURNS AND DERMAL TRAUMAS
Written by: Dr. Robert L. Bard of the Bard Diagnostic Imaging Center
Having paved the way for the study of various cancers both clinically and academically, Dr. Robert Bard co-founded the 9/11 CancerScan program to bring additional diagnostic support to all first responders from Ground Zero. His main practice in midtown, NYC (Bard Diagnostic Imaging- www.CancerScan.com) uses the latest in digital Imaging technology has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. It is used as a complement to find anomalies and help diagnose the causes of pain, swelling and infection in the body’s internal organs while allowing the diagnostician the ability to zoom and ‘travel’ deep into the body for maximum exploration.
No comments:
Post a Comment